Clinical Trial Update: A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

View source ↗

Summary

This clinical trial update summarizes the real-world experience of participants treated with BRIUMVI (ublituximab-xiiy) for Relapsing Multiple Sclerosis, with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Relapsing Multiple Sclerosis

Drugs mentioned

• BRIUMVI (ublituximab)

Snippet

Sponsor: TG Therapeutics, Inc. | Conditions: Relapsing Multiple Sclerosis, Multiple Sclerosis | Status: RECRUITING